Durable Effect of PCSK9 Antibody CompARed wiTh placEbo Study
Clinical trial NCT01516879 · COMPLETED
Trial details
- NCT number
- NCT01516879
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-05
- Primary completion
- 2013-10-14
- Enrollment
- 905
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.